CapsoVision, Inc (CV)

↓ Download CSV

CIK 0001378325 · Nasdaq · Electromedical & Electrotherapeutic Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, CapsoVision, Inc reported revenue of $13.55M, up 15.3% from the prior year. The company ran a net loss, with a net margin of -186.8% and a gross margin of 52.9%. It held $18.16M in total assets against $4.90M in total liabilities.

Key ratios (FY2025)

52.9%
Gross margin
-188.3%
Operating margin
-186.8%
Net margin
-190.9%
Return on equity
+15.3%
Revenue growth (YoY)
Metric (FY)202520242023
Revenue$13.55M$11.76M
Cost of Revenue$6.38M$5.38M
Gross Profit$7.17M$6.38M
Operating Income-$25.52M-$19.92M
Net Income-$25.32M-$19.90M
EPS (Diluted)$-1.03$-9.85
Total Assets$18.16M$16.80M
Total Liabilities$4.90M$2.69M
Shareholders' Equity$13.26M-$129.51M-$109.84M
Operating Cash Flow-$22.86M-$20.09M
Capital Expenditures$90.0K$153.0K
Shares Outstanding46.87M2.09M